European Companies Search Engine
European Union Transparency Register Eutr 17 Oct 2026 European Union Transparency Register
Overview
Text
Merck
Identification
- Registration Date: 2009-07-28
- Last Update Date: 2026-10-16
- Transparency Register ID: 49654992078-52
- Entity Form: KGaA
- Website: https://www.merckgroup.com
- Registration Category: Companies & groups
Contact Information
Head Office
- Address: Frankfurter Strasse 250, 64293 Darmstadt , GERMANY
- Phone: +49 6151720
EU Office
- Address:
Unnamed street ??, 1040 Brüssel, Germany , BELGIUM - Phone: +32 477884843
Goals
Merck, a leading science and technology company, generated total revenues of €21,1 billion in 2025 with its divisions Healthcare, Life Science and Electronics. More than 62,000 Merck employees work in 66 countries to improve the quality of life for patients, to further the success of customers and to help meet global challenges. Merck is the world’s oldest pharmaceutical and chemical company – since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70 percent stakes, the founding family remains the majority owner of the company to this day. Merck, Darmstadt, Germany is holding the global rights to the Merck name and brand. The only exceptions are the United States and Canada. Here Merck operates as EMD Serono in the Biopharma business, MilliporeSigma in the Life Science business, and as EMD Performance Materials in the Performance Materials/Electronics business.
Levels of Interest
- Sub-national
- Global
- European
- National
EU Legislative Proposals
- Industrial policies: EU Competitiveness, Digital & Clean Transition and all relevant Industrial policies/initiatives such as: Industrial Accelerator Act, Chemicals Strategy for Sustainability - REACH revision, Circular Economy policies, PFAS, CBAM, secured supply chains, Procurement rules, Sustainable Finance (eg Taxonomy), ...
- Trade policies: EU Economic Security Strategy, Free Trade Agreements and trade deals, Global Gateway, customs regulations, TTC developments,...
- Digital Policies: (i.e. Sovereignty Package, notably EU Chips-Act 2.0, AI-related initiatives - Omnibuses for simplification - Sector-specific regulations in Healthcare, Life Science and Electronic, such as Biotech Act 1 & 2, clinical trials, access to innovation, unitary SPC, NAMs, EU Chips Act 2.0,...
EU Supported Forums and Platforms
Activities in the policy areas of Pharma and Health legislation, Energy and Climate, Environment and Chemicals legislations, Biotechnology, Chips, AI and data regulations, Taxation, Sustainable Finance, Research and Development - through our Trade Associations. Merck is committed to work in partnership with the European bodies to support policies and actions that facilitates patient access to treatments for unmet medical needs, especially chronic and rare diseases, as well as aspects supporting European R&D in innovative healthcare technologies - through our Trade Associations. Merck participates to the European Partnership for Alternative Approaches to Animal testing (EPAA).
Inter or Unofficial Groupings
N/A
Staff
- Total Members: 8.0
- FTE: 4.25
- Members (75%): 4
- Members (50%): 1
- Members (25%): 3
- EP Accredited Number: 4
Interests
- Budget
- Business and industry
- Climate action
- Competition
- Consumers
- Customs
- Digital economy and society
- Economy, finance and the euro
- Environment
- External relations
- Foreign affairs and security policy
- Institutional affairs
- International co-operation and development
- Public health
- Research and innovation
- Single market
- Taxation
- Trade
Structure
- Is Member Of: see above
- Organisation Members: Merck is a member of CEFIC (EU), EFPIA (EU), SEMI Europe, EuropaBio, LSMA (Life Science Manufacturer Association), BVAC (DE with EU-office), VCI (DE) and its sub-state organisations such as LV Hessen, and DIB (Deutsche Industrievereinigung Biotechnologie), Bundesverband der deutschen Industrie (BDI), Verband forschender Arzneimittelhersteller (DE), World Economic Forum (WEF), Bitkom (DE), Cosmetics Europe, EU-Japan BRT, EUCCC (European Chamber of Commerce), ACATECH and various other sectoral organisations mainly at respective national/regional levels in the countries such as European General Counsel Association (UK), European Process Safety Center (UK), European Centre for Ecotoxicology and Toxicology of Chemicals (BE), European Partnership for Alternative Approaches to Animal testing (EPAA)
Interest Represented
Promotes their own interests or the collective interests of their members
Financial Data
Closed Year (2025-01-01 to 2025-12-01)
- Total Costs: €1,750,000 - €1,999,999
Intermediaries
| Name | Representation Costs (€) |
|---|---|
| FIPRA International SRL | 25,000 - 49,999 |
| FTI Consulting Belgium | < 10,000 |
| Acumen Public Affairs | 10,000 - 24,999 |
| NOVE | 100,000 - 199,999 |
| HARMON CORPORATE AFFAIRS, SL | < 10,000 |
| Covington & Burling LLP | < 10,000 |
Current Year
Intermediaries
- FIPRA International SRL
- NOVE
- HARMON CORPORATE AFFAIRS, SL
- Covington & Burling LLP
Complementary Information
Many critical regulations are under preparation, that will cover our sectors of activities, requiring a high level of attention.
The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: MERCK KGaA, Darmstadt, Germany.
